A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
2009
Purpose
To assess the maximum-tolerated dose (MTD), dose-limiting toxicity (DLT), pharmacokinetics and antitumor activity of Triapine® administered in combination with doxorubicin.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
33
References
28
Citations
NaN
KQI